Market Tracker

10/31 7:05pm ET

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.60
Data as of Oct 31
 -0.1082 / -6.33%
Today’s Change
1.55
Today|||52-Week Range
5.04
-44.83%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.71
Today’s open1.83
Day’s range1.55 - 1.83
Volume11,619
Average volume (3 months)37,026
Market cap$20.3M
Dividend yield--
Data as of 3:56pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
TPITianyin Pharmaceutic...+0.01+1.88%
CYANCyanotech Corp+0.11+2.33%
NUINNutrastar Internatio...+0.00+0.01%
ATOSAtossa Genetics Inc-0.10-8.40%
Data as of 3:59pm ET, 10/31/2014

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts